New practice model may reduce miscarriage after assisted reproduction
January 5, 2012 in OtherElsevier, a world-leading provider of scientific, technical and medical information products and services today announced the publication of an article in the December issue of Reproductive BioMedicine Online about miscarriage rates following IVF treatment with frozen thawed embryos which may revolutionize clinical and laboratory practice.
As the practice of freezing and transferring 'surplus' embryos widens rapidly, concerns about whether the freezing process may interfere with the viability of the embryos are often raised by patients. The study highlights that miscarriage is less likely to occur after the transfer of fresh embryos compared with frozen-thawed embryos, but also that the age of the embryos at the time of freezing could influence the miscarriage rate.
Y.A. Wang and colleagues undertook a retrospective analysis of 52,874 clinical pregnancies recorded on the Australian and New Zealand Assisted Reproduction Database (ANZARD) between 2004 and 2008 that showed that the woman's age and obstetric history are closely related to the risk of miscarriage, and that the transfer of fresh embryos is associated with fewer miscarriages than transfer of frozenthawed embryos.
The overall miscarriage rate was 18.7%; younger women (< 35 years) being almost 3 times less likely to miscarry than women > 40 years of age, and women who had an elective single embryo transfer were less likely to miscarry than if two embryos were transferred. Transferring thawed embryos which were frozen at an earlier stage of development than the blastocyst were less likely to miscarry. The authors proposed a practice model of transferring fresh blastocysts and freezing of cleavage-stage embryos to reduce the miscarriage rate after IVF and related treatments. Such a model, they claim, could lead to a substantial reduction in the miscarriage rate and eliminate much of the anxiety suffered by women undergoing Assisted Reproductive Technology.
As noted by Yacoub Khalaf, Director of the Assisted Conception Unit at Guy's and St Thomas' NHS Foundation Trust, London, in a commentary in the same issue of Reproductive BioMedicine Online, this model may have practical limitations and would need validation in a randomized trial. Large databases aggregated over many years are not free of bias and are not usually comprehensive enough to account for all the pertinent variables. Retrospective analysis of large national databases is useful in identifying trends and generating hypothesis, but evaluation of these hypotheses in randomized trials remains necessary for objective validation.
"It is interesting that miscarriage rates of frozen blastocysts were higher in the Australian study, particularly since it is well known that blastocysts have a lower frequency of chromosomal anomalies than cleaved embryos. Blastocyst culture is still a relatively new approach and culture-related factors such as selection for freezing at blastocyst stage may have affected early learning experiences in some clinics. It is therefore important to repeat a similar analysis of Australian clinic data during subsequent years," Dr. Jacques Cohen, senior editor of Reproductive BioMedicine Online, said of the study.
More information: The article is "Transfers of fresh blastocysts and blastocysts cultured from thawed cleavage embryos are associated with fewer miscarriages" by Yueping Alex Wang, Michael Costello, Michael Chapman, Deborah Black, Elizabeth Anne Sullivan (doi:10.1016/j.rbmo.2011.07.023). The article appears in Reproductive BioMedicine Online, Volume 23, Issue 6 (December, 2011).
The commentary is "The search for a practice model to reduce miscarriage after assisted reproduction" by Yakoub Khalaf, Tarek El-Toukhy (doi:10.1016/j.rbmo.2011.09.014). The commentary appears in Reproductive BioMedicine Online, Volume 23, Issue 6 (December, 2011).
Provided by
Elsevier
-
Single thawed embryo transfer after PGD does not affect pregnancy rates
Jun 30, 2009 |
not rated yet |
0
-
Children born from frozen embryos weigh more and do better than those born after fresh transfer
Jul 08, 2008 |
not rated yet |
0
-
Baby born from embryo frozen almost 20 years ago
Oct 12, 2010 |
not rated yet |
0
-
Swedish model slashes multiple-birth risk in IVF pregnancies
Jul 04, 2011 |
not rated yet |
0
-
Researchers report technique for freezing and preserving genetically enhanced pig embryos
May 03, 2006 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
May 25, 2012 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Transvaginal mesh op restores pelvic organ prolapse at price
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...
Other
12 hours ago |
not rated yet |
0
Tongue analysis software uses ancient Chinese medicine to warn of disease
For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...
Other
May 25, 2012 |
1 / 5 (1) |
0
|
Neck strength, cervical spine mobility don't predict pain
(HealthDay) -- Neither isometric neck muscle strength nor passive mobility of the cervical spine, two physical capacity parameters found to be associated with neck pain in other studies, predicts later neck ...
Other
May 25, 2012 |
not rated yet |
0
Pool access for the disabled sparks controversy
(AP) -- The Obama administration is sidestepping an election-year confrontation with the hotel industry and other pool owners to give them more time to comply with access rules for the disabled.
Other
May 25, 2012 |
not rated yet |
0
Chile to cover sex change operations
Chile will soon cover sex change surgeries under its public health plan in order to allow citizens of limited means to "recover their true sexual identity," Health Minister Jaime Manalich said.
Other
May 25, 2012 |
not rated yet |
0
Keep food safety in mind this memorial day weekend
(HealthDay) -- Picnics, parades and cookouts are as much a part of Memorial Day weekend as tributes to the United States' war veterans.
Travel to high altitudes tied to Crohn's, colitis flare-ups
(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...
Family history of Alzheimer's affects functional connectivity
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Weight struggles? Blame new neurons in your hypothalamus
New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.